The study suggests a colon-targeted herbal treatment altered metabolic and immune pathways and reduced inflammation in a rat model of ulcerative colitis, which could point to new therapeutic approaches to explore for UC...

People with Crohn's disease may be interested because the paper provides molecular hypotheses linking acupuncture to immune-related pathways (neutrophils, M2 macrophages) and nominates FER as a potential...

Perianal fistulas are a common, disabling complication of Crohn’s disease. A medication that provides durable fistula remission through 48 weeks could change treatment options for people with Crohn’s and perianal...

These Phase 3 results suggest guselkumab (TREMFYA) may provide durable clinical and endoscopic benefit through three years for adults with moderate to severe Crohn’s disease and may help with perianal fistula...

Cure8 could only read part of this source from marketscreener.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Guselkumab.

This study uses transcriptomics, single‑cell data, and machine learning to nominate lactylation‑related genes as biomarkers and drug targets in ulcerative colitis, which could guide future biomarker or drug‑repurposing...

The study explores whether people with UC in deep histologic remission can reduce or stop maintenance medications without losing remission — a question many patients and clinicians face because of medication costs, side...

Cure8 could only read part of this source from marketscreener.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical...

A combo that adds an α4β7 blocker to an IL-23 inhibitor showed higher endoscopic remission at Week 12 than either drug alone in a phase 2 Crohn’s trial, which could point to a new treatment strategy for people who’ve...

Mid-stage data suggest a dual-targeting approach may improve endoscopic remission for people with moderate–severe Crohn's disease, including many who previously failed advanced therapies. If confirmed in larger trials,...

An experimental mouse study suggests gastrodin may reduce colitis severity and associated anxiety/depression-like behaviours while changing gut microbiota, metabolites, and intestinal inflammation — an early preclinical...

The report suggests a dual-targeting antibody combination (IL-23 p19 + α4β7) may achieve higher endoscopic remission than either mechanism alone in a treatment-experienced Crohn's population, which could matter for...

This review summarizes how ulcerative colitis trials have been designed recently and flags common weaknesses (small samples, short follow-up, overreliance on Mayo score). Better-designed trials could produce results that...

Personal stories can help people with IBD feel seen and show that fatigue and pain from Crohn’s disease don’t always prevent meaningful physical activity or community involvement. It also highlights fundraising and...

Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease and Complications. The original article is from British journal of haematology.

If validated, antibody signatures could enable earlier identification of people at higher risk of developing IBD and help predict which patients may develop more severe disease, creating opportunities for earlier...

If validated, antibody-based signatures could enable much earlier detection of IBD and help identify people at risk of more severe Crohn’s disease years before symptoms—potentially opening opportunities for research on...

If validated, blood antibody patterns could allow earlier identification of people at risk for Crohn’s disease or ulcerative colitis — potentially before bowel damage occurs — opening opportunities for earlier monitoring...

Based on the title and source metadata, this appears to be a video related to Procedures and surgery. The original article is from hmpgloballearningnetwork.com.

Researchers are exploring targeted oral delivery and immune‑modulating strategies for colitis in older hosts; this study suggests a nanoparticle approach can alter T cell aging signs and the gut microbiome in mice, which...

The study identifies a molecular mechanism that links immune cell metabolism (Th17 glycolysis) with intestinal inflammation and colitis-associated cancer in experimental models. That pathway could eventually yield new...

Based on the title and source metadata, this appears to be a guideline related to Ulcerative colitis, Inflammatory bowel disease, and Colectomy. The original article is from Techniques in Coloproctology.

Researchers are exploring targeted oral delivery methods to improve treatment of colitis in older individuals. If translatable, a colon-targeted nanogel that boosts regulatory T cells and favorably shifts the microbiome...

Blood platelet indices (PLR, MPV) are simple blood-test measures that may help detect IBD activity and show changes with biologic treatment. If validated, they could offer an inexpensive, noninvasive way to supplement...

Crohn’s disease can rarely affect the nose and nasopharynx. Recognizing this can shorten diagnostic delay and lead to appropriate immunosuppressive or biologic treatment that may prevent complications.

A simple, low-cost fecal blood assay for mice can speed and lower the cost of preclinical studies of colorectal cancer and GI diseases. For IBD/Crohn’s research, it offers a way to monitor intestinal bleeding and link it...

The study suggests people with IBD consumed more dietary emulsifiers than healthy controls and found initial links between higher UPF/emulsifier intake and worse IBD-related events, which could be important if diet...

Nutritional disorders in IBD (underweight/malnutrition, overweight/obesity, and muscle loss/sarcopenia) are common and affect treatment tolerance, recovery, and quality of life. Knowing how frequent these problems are...

The study identifies a specific fibroblast–macrophage interaction driven by collagen IV that may explain how chronic IBD inflammation progresses to fibrosis and cancer, highlighting possible new molecular targets to...

Children with IBD can present differently than adults and may show early signs outside the gut. The special-issue papers highlight improved, less-invasive diagnostic tools and increasing use of targeted biologic...

Based on the title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, and Upadacitinib. The original article is from moomoo.com.

Fibrostenotic strictures are a major unmet need in Crohn’s disease because anti-inflammatory drugs often cannot reverse established scarring; IL-11 is a biologically plausible target that might selectively affect...

Based on the title and source metadata, this appears to be a systematic review or meta analysis related to Inflammatory bowel disease, Infliximab, and Anti-TNF. The original article is from Current Gastroenterology...

Cure8 found this source from moosejawtoday.com, but the page could not be read reliably yet. It is tagged for Community and awareness. Open the original article for the full details.

Mentions of Sewa Kroetkov’s past Crohn’s disease explain why his skating comeback may matter to fans and to communities tracking athletes with chronic illness, but the article itself is focused on skateboarding team news...

Fatigue is a common, disabling issue in Crohn’s disease with unclear biology. This study suggests measurable brain-structure differences correlate with fatigue severity and may modify how disease activity influences...

The article discusses peptide compounds that people with Crohn’s and other IBDs are exploring for gut barrier support and inflammation — a topic many patients consider when seeking adjunctive or experimental approaches.

Cure8 found this source from streetinsider.com, but the page could not be read reliably yet. It is tagged for Inflammatory bowel disease and Medications. Open the original article for the full details.

Surgical site infection is a common and serious complication after IBD surgery. The paper highlights that antibiotic-resistant bacteria (ESBLs, MRSA) were common in this Saudi cohort and that standard cephalosporin...

If true, the findings suggest that everyday chemicals (bisphenols) might influence immune pathways relevant to IBD and that RORC could be a molecular link — potentially relevant for researchers studying environmental...

Some infections (here, HIV) can closely mimic very early onset IBD. Recognizing progressive lymphopenia or unusual infections can change diagnosis and treatment, which matters because immunosuppression can worsen...

IUS with the IBUS‑SAS score may offer a reliable, noninvasive way to monitor Crohn’s disease activity that correlates with clinical scores and biomarkers and aligns well with CT/MRI for most findings.

Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease and Research and clinical trials. The original article is from Probiotics and Antimicrobial Proteins.

Peptides are being studied for targeted ways to reduce gut inflammation and help restore the intestinal lining — potential relevance for future Crohn’s/IBD therapies.

People with Crohn’s or IBD often try nutritional supplements; this article surveys claims and early research about collagen peptides that some hope could support gut lining and reduce inflammation. It’s useful for...

Cure8 found this source from intellectia.ai, but the page could not be read reliably yet. It is tagged for Inflammatory bowel disease and Research and clinical trials. Open the original article for the full details.

Longer-term and real-world data help patients and clinicians understand how well risankizumab and upadacitinib maintain clinical and endoscopic improvement over years of treatment, and early data on an investigational...

Cure8 found this source from pluang.com, but the page could not be read reliably yet. It is tagged for Inflammatory bowel disease, Risankizumab, and Upadacitinib. Open the original article for the full details.